Ad
related to: augmentin for community acquired pneumonia- Pharmacy Network Finder
Use the finder to locate
pharmacies that carry our drug
- Request A Rep / Sample
Fill in a form and request
a sample or a representative.
- CABP Patient Types
See if your patients could be
eligible for this treatment.
- ABSSSI Patient Types
See if your patients could be
eligible for this treatment.
- Pharmacy Network Finder
Search results
Results from the WOW.Com Content Network
Community-acquired pneumonia (CAP) refers to pneumonia (any of several lung diseases) contracted by a person outside of the healthcare system. In contrast, hospital-acquired pneumonia (HAP) is seen in patients who have recently visited a hospital or who live in long-term care facilities.
[13] [15] Pneumonia is also the leading cause of death in children less than five years of age in low income countries. [15] The most common cause of pneumonia is pneumococcal bacteria, Streptococcus pneumoniae accounts for 2/3 of bacteremic pneumonias. [16] Invasive pneumococcal pneumonia has a mortality rate of around 20%. [14]
Amoxicillin is an antibiotic while clavulanic acid is a non-antibiotic β-lactamase inhibitor which prevents metabolism of amoxicillin by certain bacteria. In addition to its β-lactamase inhibition, clavulanic acid shows central nervous system actions and effects and has been studied in the potential treatment of various psychiatric and ...
The choice of antibiotic will depend on several factors, including the suspected causative organism and whether pneumonia was acquired in the community or developed in a hospital setting. Common options include clindamycin , a combination of a beta-lactam antibiotic and metronidazole , or an aminoglycoside. [ 137 ]
The treatment options for bacterial pneumonia is antibiotic therapy. Dependent on the severity of the case some may require hospitalization, especially when risk factors may make one more susceptible. The typical antibiotics prescribed to treat community and hospital acquired pneumonia is amoxicillin plus a macrolide. [44]
The FDA said the drug was “nonapprovable”, but did not refer to specific safety concerns about the product. The company will have to conduct new studies and clinical trials, lasting an estimated two more years, to prove the drug treats community-acquired pneumonia, bacterial sinusitis, chronic bronchitis, and skin infections. [citation needed]
Pneumococcal pneumonia is a type of bacterial pneumonia that is caused by Streptococcus pneumoniae (pneumococcus). [1] It is the most common bacterial pneumonia found in adults, the most common type of community-acquired pneumonia, and one of the common types of pneumococcal infection. The estimated number of Americans with pneumococcal ...
Community-acquired pneumonia (CAP) is infectious pneumonia in a person who has not recently been hospitalized. CAP is the most common type of pneumonia. The most common causes of CAP vary depending on a person's age, but they include Streptococcus pneumoniae, viruses, the atypical bacteria, and Haemophilus influenzae.
Ad
related to: augmentin for community acquired pneumonia